Submission Details
| 510(k) Number | K925900 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 20, 1992 |
| Decision Date | August 24, 1993 |
| Days to Decision | 277 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K925900 is an FDA 510(k) clearance for the LACEY REVISION FEMORAL COMPONENT, a Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer/metal/polymer (Class II — Special Controls, product code JWH), submitted by Dow Corning Wright (Arlington, US). The FDA issued a Cleared decision on August 24, 1993, 277 days after receiving the submission on November 20, 1992. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3560.
| 510(k) Number | K925900 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 20, 1992 |
| Decision Date | August 24, 1993 |
| Days to Decision | 277 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | JWH — Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer/metal/polymer |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3560 |